Advertisement

Elective Abortion Techniques, Risks, and Complications

  • Gwen P. Gentile
  • Richard H. Schwarz

Abstract

The advent of prenatal diagnosis of hereditary disorders has brought with it the utilization of pregnancy termination as the predominant preventive approach, since in almost all instances this is the only recourse. Indeed, in its early days, the acceptance of the abortion alternative was considered by many to be a prerequisite to prenatal diagnosis. This posture has been modified, but an explanation of the techniques and risks of elective abortion must be an important part of the counseling process. There are three major considerations in elective abortion for genetic disorders. First, the variety of techniques available must be evaluated with regard to their efficacy at the period of gestation under consideration. Second, the risks of these methods must be carefully assessed and presented to the patient. Third, but less important, the suitability of the aborted material for corroborative cytogenetic and biochemical study must be considered. This chapter will review each of the methods from these three perspectives, but will place particular emphasis on the method felt most appropriate for the majority of cases.

Keywords

Pregnancy Termination Amniotic Fluid Disseminate Intravascular Clotting Hypertonic Saline Uterine Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aiken, J. W., 1972, Aspirin and indomethacin prolong parturition in rats: Evidence that prostaglandins contribute to the expulsion of foetus, Nature 240:21.PubMedCrossRefGoogle Scholar
  2. Beller, F. K., Rosenberg, M., Kolker, M., et al., 1972, Consumptive coagulopathy associated with intra-amniotic infusion of hypertonic salt, Am. J. Obstet. Gynecol. 112:534.PubMedGoogle Scholar
  3. Bengtsson, L. P., and Csapo, A., 1962, Oxytocin response, withdrawal and reinforcement of defense mechanism of the human uterus at midpregnancy, Am. J. Obstet. Gynecol. 83:1083.PubMedGoogle Scholar
  4. Berger, G. S., and Kerenyi, T. D., 1974, Analysis of retained placenta associated with saline abortion: Methodologic considerations, Am. J. Obstet. Gynecol. 120:479.PubMedGoogle Scholar
  5. Berger, G. S., Edelman, D. A., and Kerenyi, T. D., 1975, Oxytocin administration instillation-to-abortion time and morbidity associated with saline instillation, Am. J. Obstet. Gynecol. 121:941.PubMedGoogle Scholar
  6. Bhalla, K., and Jenkins, C. R. M., 1982, Intramuscular administration of 15-methyl prostaglandin F2α in mid-trimester termination of pregnancy, J. Int. Med. Res. 10:32.PubMedGoogle Scholar
  7. Binkin, N. J., Schulz, K. F., Grimes, D. A., et al., 1983, Urea-prostaglandin versus hypertonic saline for instillation abortion, Am. J. Obstet. Gynecol. 146:947.PubMedGoogle Scholar
  8. Blumberg, B. D., Golbus, M. S., and Hanson, K. H., 1975, The psychological sequelae of abortion performed for a genetic indication, Am. J. Obstet. Gynecol. 122:799.PubMedGoogle Scholar
  9. Brenner, W. E., 1979, Abortion of early midtrimester pregnancy with commercially available prostaglandins, in: Pregnancy Termination: Procedures Safety, and New Developments (G.I. Zatuchni, J.J. Sciarra, and J. J. Speidel, eds.), p. 218, Harper and Row, Hagerstown.Google Scholar
  10. Brenner, W. E., Dingfelder, J. R., Staurovsky, L. G., et al., 1974, Intramuscular administration of 15(S)-15-methyl-prostaglandin E2-methylester for induction of abortion, Am. J. Obstet. Gynecol. 120:833.PubMedGoogle Scholar
  11. Brewer, L. L., Johnson, W. L., and Hunter, C. A., 1968, Effects of intra-amniotic injection of hypertonic saline on uterine activity, blood and amniotic fluid volumes and electrolyte concentrations, Am. J. Obstet. Gynecol. 101:1078.PubMedGoogle Scholar
  12. Burkman, R. T., Atienza, M. F., King, T. M., et al., 1976, Intra-amniotic urea and prostaglandin F2 for mid-trimester abortion: A modified regimen, Am. J. Obstet. Gynecol. 126:328.PubMedGoogle Scholar
  13. Burkman, R. T., Atienza, M. F., King, T. M., et al., 1978, Hyperosmolar urea for elective midtrimester abortion. Experience in 1,913 cases, Am. J. Obstet. Gynecol. 131:10.PubMedGoogle Scholar
  14. Burkman, R. T., Dubin, N. H., and King, T. M., 1979, The use of hyperosmolar urea for the elective abortion of midtrimester pregnancy, in: Pregnancy Termination: Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 261, Harper and Row, Hagerstown.Google Scholar
  15. Burkman, R. T., King, T. M., and Atienza, M. F., 1981, Hyperosmolar urea, in: Second Trimester Abortion: Perspectives after a Decade of Experience (G. S. Berger, W. E. Brenner, and L. G. Keith, eds.), p. 107, John Wright, Boston.Google Scholar
  16. Burnett, L. S., Wentz, A. C., and King, T. M., 1974, Techniques of pregnancy termination. Part II, Obstet. Gynecol. Surv. 29(1):6.PubMedCrossRefGoogle Scholar
  17. Burnett, L. S., King, T. M., Atienza, M. F., et al., 1975, Intra-amniotic urea as a mid-trimester abortifa-cient: Clinical results and serum and urinary changes, Am. J. Obstet. Gynecol. 121:7.PubMedGoogle Scholar
  18. Burnhill, M. S., Gaines, J. A., and Guttmacher, A. F., 1962, Concentrated oxytocin solution for therapeutic interruption of mid-trimester pregnancy, Obstet. Gynecol. 20:94.PubMedCrossRefGoogle Scholar
  19. Butler, J. C., 1979, Ethacridine-catheter technique for midtrimester abortion, in: Pregnancy Termination: Procedures, Safety and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 277, Harper and Row, Hagerstown.Google Scholar
  20. Bygdeman, M. A., 1981, Prostaglandin procedures, in: Second Trimester Abortion Perspectives after a Decade of Experience (G. S. Berger, W. E. Brenner, and L. G. Keith, eds.), p. 89, John Wright, Boston.Google Scholar
  21. Cates, W., Jr., Schulz, K. F., Gold, J., et al., 1979, Complications of surgical evacuation procedures for abortions after 12 weeks’ gestation, in: Pregnancy Termination: Procedures, Safety and New Developments (G. I. Zatuchni, J. J. Sciarra, J. J. Speidel, eds.), p. 206, Harper and Row, Hagerstown.Google Scholar
  22. CDC, 1983, Abortion Surveillance: Annual Summary 1979–1980, Center for Disease Control, Atlanta, Georgia.Google Scholar
  23. Corson, S. L., and Bolognese, R. J., 1975a, Vaginally administered prostaglandin E2 as a first and second trimester abortifacient, J. Reprod. Med. 14:43.PubMedGoogle Scholar
  24. Corson, S. L., and Bolognese, R. J., 1975b, Intra-amniotic prostaglandin F2α as a mid-trimester abortifacient: Effect of oxytocin and laminaria, J. Reprod. Med. 14:47.PubMedGoogle Scholar
  25. Csapo, A. I., and Wiest, W. G., 1972, On the mechanism of the abortifacient action of prostaglandin F2α, Prostaglandins 1:157.CrossRefGoogle Scholar
  26. Csapo, A. I., Kivikovski, A., and Wiest, W. G., 1972a, Mid-trimester abortions induced by intra-amniotic prostaglandin F2α, Prostaglandins 1:305.CrossRefGoogle Scholar
  27. Csapo, A. I., Kivikovski, A., and Weist, W. G., 1972b, Massive initial prostaglandin impact in post-conceptional therapy, Prostaglandins 2:125.CrossRefGoogle Scholar
  28. Csapo, A. I., Csapo, E. F., Fay, E., et al., 1973a, The delay of spontaneous labor by naproxen in the rat model, Prostaglandins 3:827.PubMedCrossRefGoogle Scholar
  29. Csapo, A. I., Pulkinnen, M. O., and Kaihola, H. L., 1973b, The effect of luteectomy-induced progesterone withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus, Prostaglandins:421.Google Scholar
  30. Daling, J. R., and Emanuel, I., 1977, Induced abortion and subsequent outcome of pregnancy in a series of American women, N. Engl. J. Med. 297:1241.PubMedCrossRefGoogle Scholar
  31. Dayan, A. D., Cameron, J. M., and Phillipp, E., 1967, Fatal brain damage associated with therapeutic abortion induced by amniocentesis: Report of one case, Med. Sci. Law 7:70.PubMedGoogle Scholar
  32. De Cherney, A. H., Schwarz, R. H., and Drobney, H., 1972, Infection as a complication of therapeutic abortion, Pa. Med. 12:49.Google Scholar
  33. Dillon, T. F., Phillips, L. L., Risk, A., et al., 1975, The efficacy of intramuscular 15 methyl prostaglandin E2 in second-trimester abortion, Am. J. Obstet. Gynecol. 121:584.PubMedGoogle Scholar
  34. Droegemueller, W., and Greer, B. E., 1970, Saline versus glucose as a hypertonic solution for abortion, Am. J. Obstet. Gynecol. 108:606.PubMedGoogle Scholar
  35. Easterling, W. E., Jr., Weiss, A. E., Odom, M. H., et al., 1972, Plasma volume, electrolyte and coagulation factor changes following intra-amniotic hypertonic saline infusion, Am. J. Obstet. Gynecol. 113:1065.PubMedGoogle Scholar
  36. Fuchs, F., 1967, Termination of pregnancy by intra-amniotic injection of hypertonic solutions, in: Advances in Obstetrics and Gynecology (S. L. Marcus and C. C. Marcus, eds.), p. 258, Williams and Wilkins, Baltimore.Google Scholar
  37. Fuchs, F., Fuchs, A. R., Short, R. V., et al., 1965, Uterine motility and concentration of progesterone in uterine venous blood after intra-amniotic injection of hypertonic saline, Acta Obstet. Gynecol. Scand. 44:63.PubMedCrossRefGoogle Scholar
  38. Fylling, P., 1982, Experience with 16-phenoxy-w-tetranor-PGE2-methylsulfonamide (Sulprostone) for termination of second trimester pregnancy, Contraception 26(3):279.PubMedCrossRefGoogle Scholar
  39. Gardner, H. A., Wood, E. M., and Stecker, E., 1976, Placenta cultures for cytogemetic assessment in saline-aborted fetuses, Am. J. Obstet. Gynecol. 126:350.PubMedGoogle Scholar
  40. Gillett, P. G., 1979, Therapeutic abortion in the late second trimester: Experience with prostaglandins, in: Pregnancy Termination: Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 268, Harper and Row, Hagerstown.Google Scholar
  41. Gochberg, S. H., and Ried, D. E., 1966, Intra-amniotic injection of hypertonic saline for termination of pregnancy, Obstet. Gynecol. 27:648.PubMedGoogle Scholar
  42. Goldman, J. A., and Eckerling, B., 1972, Intracranial dural sinus thrombosis following intrauterine instillation of hypertonic saline, Am. J. Obstet. Gynecol. 112:1132.PubMedGoogle Scholar
  43. Goodlin, R. C., Kresch, A. J., and Northway, W. H., 1968, Volume changes in amniotic fluid following intra-amniotic saline injection, Obstet. Gynecol. 31:240.PubMedCrossRefGoogle Scholar
  44. Greer, B. E., Droegemueller, W., and Engle, T., 1975, Preliminary experience with 15 (s) 15-methyl prostaglandin F2α for mid-trimester abortion, Am. J. Obstet. Gynecol. 121:524.PubMedGoogle Scholar
  45. Grimes, D. A., and Cates, W., Jr., 1981, Dilatation and evacuation, in: Second Trimester Abortion: Perspectives after a Decade of Experience (G. S. Berger, W. E. Brenner, and L. G. Keith, eds.), p. 119, John Wright, Boston.Google Scholar
  46. Grimes, D. A., Schulz, K. F., Cates, W., Jr., et al., 1980, The safety of midtrimester abortion, in: The Safety of Fertility Control (L. G. Keith, D. R. Kent, G. S. Berger, et al., eds.), p. 198, Springer, New York.Google Scholar
  47. Haning, R. V., Jr., and Peckham, B. M., 1985, Evaluation of intra-amniotic administration of 120 gm of urea with 5 mg of prostaglandin F2α for midtrimester termination of pregnancy between 20 and 24 weeks’ gestation, Am. J. Obstet. Gynecol. 151:92.PubMedGoogle Scholar
  48. Hanson, M. S., 1979, Midtrimester abortion: Dilatation and extraction preceded by laminaria, in: Pregnancy Termination: Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 191, Harper and Row, Hagerstown.Google Scholar
  49. Hern, W. M., 1984, Abortion Practice, Lippincott, Philadelphia.Google Scholar
  50. Hogue, C., 1974, Low birth weight subsequent to induced abortion, Am. J. Obstet. Gynecol. 120:166.Google Scholar
  51. Ingemanson, C.-A., 1979, The ethacridine-catheter method in second-trimester abortion, in: Pregnancy Termination Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 282, Harper and Row, Hagerstown.Google Scholar
  52. Ju, K. S., Park, I. J., and Jones, H. W., Jr., 1976, The culturability of fibroblasts from the skin of abortuses after intra-amniotic instillation of urea or prostaglandin, Am. J. Obstet. Gynecol. 125:1155.PubMedGoogle Scholar
  53. Karim, S. M. M., and Filshie, G. M., 1970, Therapeutic abortion using prostaglandin F2α, Lancet 1:157.PubMedCrossRefGoogle Scholar
  54. Kerenyi, T. D., 1981, Hypertonic saline instillation, in: Second Trimester Abortion: Perspectives after a Decade of Experience (G. S. Berger, W. E. Brenner, and L. G. Keith, eds.), p. 79, John Wright, Boston.Google Scholar
  55. King, T. M., Dubin, N. H., Atienza, M. F., et al., 1977, Intra-amniotic urea and prostaglandin F2α for midtrimester abortion. Clinical and laboratory evaluation, Am. J. Obstet. Gynecol. 129:817.PubMedGoogle Scholar
  56. Kline, J., Stein, Z., Susser, M., et al., 1978, Induced abortion and spontaneous abortion: No connection?, Am. J. Epidemiol. 107:290.PubMedGoogle Scholar
  57. Kloeck, F. K., and Jung, H., 1973, In vitro release of prostaglandins from the human myometrium under the influence of stretching, Am. J. Obstet. Gynecol. 115:1066.PubMedGoogle Scholar
  58. Lauersen, N. H., 1980, Prostaglandins and fertility control, in: The Safety of Fertility Control (L. G. Keith, D. R. Kent G. S. Berger, et al., eds.), p. 191, Springer, New York.Google Scholar
  59. Lauersen, N. H., and Wilson, K. H., 1974, Continuous extraovular administration of prostaglandin F2α for mid-trimester abortion, Am. J. Obstet. Gynecol. 120:273.PubMedGoogle Scholar
  60. Lauersen, N. H., and Wilson, K. H., 1975, Mid-trimester abortion induced by serial intramuscular injections of 15(s)-15-methylprostaglandin F2α, Am. J. Obstet. Gynecol. 121:273.PubMedGoogle Scholar
  61. Lewis, R. B., and Schulman, J. D., 1973, Influence of acetysalicylic acid and inhibitor of prostaglandin synthesis on the duration of human gestation and labour, Lancet 2:1159.PubMedCrossRefGoogle Scholar
  62. Lischke, J. H., and Gordon, H. R., 1974, Cervicovaginal fistula complicating induced mid-trimester abortion despite laminaria tent insertion, Am. J. Obstet. Gynecol. 120:852.PubMedGoogle Scholar
  63. Manabe, Y., 1967, Metreurynter-induced abortions at mid-pregnancy, Am. J. Obstet. Gynecol. 99:557.PubMedGoogle Scholar
  64. Manabe, Y., and Nakajima, N., 1972, Laminaria-metreurynter method of mid-term abortion in Japan, Obstet. Gynecol. 40:612.PubMedGoogle Scholar
  65. Nishimura, T., and Manabe, Y., 1967, Oxytocin sensitivity and effects of estrogen and progesterone on metreurynter induced abortions at midpregnancy, Am. J. Obstet. Gynecol. 98:1087.PubMedGoogle Scholar
  66. Osborn, R. H., Goplerod, C. P., and Yannone, M. E., 1968, Response of peripheral plasma progesterone concentration to intra-amniotic hypertonic saline, Am. J. Obstet. Gynecol. 101:1073.PubMedGoogle Scholar
  67. Park, I. J., Wentz, A. C., and Jones, H. W., Jr., 1973, The viability of fetal skin of abortuses induced by saline on prostaglandin, Am. J. Obstet. Gynecol. 115:274.PubMedGoogle Scholar
  68. Peel, J., 1962, Inducing labor by intra-amniotic injection, Br. Med. J. 2:1397.CrossRefGoogle Scholar
  69. Perry, G., Schulman, H., and Wong, T. C., 1974, Modified saline abortion for medically high risk patients, Obstet. Gynecol. 44:571.PubMedGoogle Scholar
  70. Peterson, W. F., 1979, Dilatation and evacuation: Patient evaluation and surgical techniques, in: Pregnancy Termination: Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 184, Harper and Row, Hagerstown.Google Scholar
  71. Propping, D., Stubblefield, P. G., Golub, J., et al., 1977, Uterine rupture following midtrimester abortion by laminaria, prostaglandin F2α, and oxytocin: Report of two cases, Am. J. Obstet. Gynecol. 128:689.PubMedGoogle Scholar
  72. Puri, S., Aleem, F., and Schulman, H., 1976, A histologic study of the placentas of patients with saline and prostaglandin-induced abortion, Obstet. Gynecol. 48:216.PubMedGoogle Scholar
  73. Robins, J., and Surrago, E. J., 1982, EQrly midtrimester pregnancy termination: A comparison of dilation and evacuation and intravaginal prostaglandin E2, J. Reprod. Med. 27(7):415.PubMedGoogle Scholar
  74. Roht, L. H., and Aoyama, H., 1974, Induced abortion and its sequellae: Prematurity and spontaneous abortion, Am. J. Obstet. Gynecol. 120:868.PubMedGoogle Scholar
  75. Roth-Brandel, U., Bygdeman, M., Wiquist, N., et al., 1970, Prostaglandins for induction of therapeutic abortion, Lancet 1:190.PubMedCrossRefGoogle Scholar
  76. Sakamoto, S., Satoh, K., Nishiya, I., et al., 1982, Abortifacient effect and uterine cervix-dilating action of 16,16-dimethyl trans Δ2 PGE1 methyl ester (Ono 802) in the form of a vaginal suppository (A randomized, double-blind, controlled study in the second trimester of pregnancy), Prostaglandins 9:349.Google Scholar
  77. Saldana, L. R., Schulman, H., Yang, W. H., et al., 1974a, Mid-trimester abortion by prostaglandin impact, Obstet. Gynecol. 44:579.Google Scholar
  78. Saldana, L. R., Schulman, H., and Yang, W. H., 1974b, On the mechanism of midtrimester abortions induced by the prostaglandin “impact,” Prostaglandins 3:847.CrossRefGoogle Scholar
  79. Schulman, J. D., and Lauersen, N. H., 1971, Oxytocin administration in abortions induced with hypertonic saline, Lancet 1:606.Google Scholar
  80. Seppala, M., Kajanoja, P., Widholm, O., et al., 1972, Prostaglandin induced abortion: A clinical trial on intra-amniotic prostaglandin F2α in combination with intravenous oxytocin, Prostaglandins 2:311.PubMedCrossRefGoogle Scholar
  81. Sherman, D. H., 1975, Salting out: Experience in 9000 cases, J. Reprod. Med. 14:241.PubMedGoogle Scholar
  82. Stander, R. W., Flessa, H. C., Glueck, H. I., et al., 1971, Changes in maternal coagulation factors after intra-amniotic injection of hypertonic saline, Obstet. Gynecol. 37:660.PubMedGoogle Scholar
  83. Stubblefield, P. G., 1981a, Midtrimester abortion by curettage procedures: An overview, in: Abortion and Sterilization: Medical and Social Aspects (J. E. Hodgson ed.), p. 279, Grune and Stratton, New York.Google Scholar
  84. Stubblefield, P. G., 1981b, Laminaria and other adjunctive methods, in: Second Trimester Abortion: Perspectives after a Decade of Experience (G. S. Berger, W. E. Brenner, and L. G. Keith, eds.), p. 135, John Wright, Boston.Google Scholar
  85. Stubblefield, P. G., and Naftolin, F., 1974, Letter: Use of laminaria to prevent cervical injury during abortion, Am. J. Obstet. Gynecol. 120:298.PubMedGoogle Scholar
  86. Toaff, R., Ayalon, D., and Gogel, G., 1971, Clinical use of high concentration oxytocin drip, Obstet. Gynecol. 37:112.PubMedGoogle Scholar
  87. Van Der Slikke, J. W., and Treffers, P. E., 1978, Influence of induced abortion on gestational duration in subsequent pregnancies, Br. Med. J. 1:270.PubMedCrossRefGoogle Scholar
  88. Van Lith, D. A. F., Beekhuizen, W., and Van Schie, K. J., 1979, Complications of aspirotomy (AT): A modified dilatation and curettage procedure for terminating early second-trimester pregnancies, in: Pregnancy Termination: Procedures, Safety, and New Developments (G. I. Zatuchni, J. J. Sciarra, and J. J. Speidel, eds.), p. 193, Harper and Row, Hagerstown.Google Scholar
  89. Waltman, R., Tricomi, V., and Pavlav, A. B., 1972, Mid-trimester hypertonic saline-induced abortion: Effect of indomethacin on induction/abortion time, Am. J. Obstet. Gynecol. 114:829.PubMedGoogle Scholar
  90. Waltman, R., Tricomi, V., and Shabanah, E. H., 1973, The effect of anti-inflammatory drugs on parturition parameters in the rat, Prostaglandins 4:93.PubMedCrossRefGoogle Scholar
  91. Weinberg, P. C., Linman, J. E., and Linman, S. K., 1975, Intraamniotic urea for induction of mid-trimester pregnancy termination, Obstet. Gynecol. 45:325.Google Scholar
  92. Wentz, A. C., Burnett, L. S., Atienza, M. F., et al., 1973a, Experience with intraamniotic prostaglandin F2α for abortion, Am. J. Obstet. Gynecol. 117:513.PubMedGoogle Scholar
  93. Wentz, A. C., Thompson, B. H., and King, T. M., 1973b, Posterior cervical rupture following prostaglandin induced mid-trimester abortion, Am. J. Obstet. Gynecol. 115:1107.PubMedGoogle Scholar
  94. WHO, 1979, World Health Organization Task Force on the Sequelae of Abortion: Gestation, birthweight, and spontaneous abortion in pregnancy after induced abortion, Lancet 1:142.Google Scholar
  95. Wiqvist, N., Bygdeman, M., and Kwon, S., 1960, Effect of prostaglandin E on the mid-pregnant human uterus: Intravenous, intramuscular and vaginal administration, Am. J. Obstet. Gynecol. 102:327.Google Scholar
  96. Wiqvist, N., Bydgeman, M., and Toppozada, M., 1973, Intra-amniotic prostaglandin administration—A challenge to the currently used methods for induction of mid-trimester abortion, Contraception 8:113.PubMedCrossRefGoogle Scholar

Copyright information

© Aubrey Milunsky 1986

Authors and Affiliations

  • Gwen P. Gentile
    • 1
  • Richard H. Schwarz
    • 1
  1. 1.Department of Obstetrics and GynecologyState University of New York Health Science Center at BrooklynBrooklynUSA

Personalised recommendations